Kamin-Lewis R, Abdelwahab S F, Trang C, Baker A, DeVico A L, Gallo R C, Lewis G K
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9283-8. doi: 10.1073/pnas.161298998. Epub 2001 Jul 24.
The synthesis of antiviral beta-chemokines has joined cytolysis as a potential mechanism for the control of HIV-1 infection by CD8(+) T cells. Recent evidence suggests that these two effector functions can diverge in some individuals infected with HIV-1; however, little is known about the CD8(+) T cell subsets in normal individuals that synthesize antiviral beta-chemokines. In this report, we have used mutliparameter flow cytometry to characterize the T cell subsets that secrete the antiviral beta-chemokine macrophage inflammatory protein (MIP)-1beta. These studies have shown: (i) CD8(+) cells are the predominant T cell subset that synthesizes MIP-1beta; (ii) MIP-1beta and IFN-gamma are synthesized congruently in most CD8(+) T cells; however, significant numbers of these cells synthesize only one of these effector molecules; (iii) approximately 60% of the CD8(+) T cells that synthesize MIP-1beta lack perforin; (iv) MIP-1beta is synthesized with approximately equal frequency by CD28(+) and CD28(-) subpopulations of CD8(+) T cells; (v) MIP-1beta is synthesized by three distinct CD8(+) T cell subsets defined by the expression of CD45R0 and CD62L; and (vi) MIP-1beta is not synthesized in short-term cultures of naive CD8(+) T cells. These results demonstrate substantial subset heterogeneity of MIP-1beta synthesis among CD8(+) T cells and suggest that these subsets should be evaluated as correlates of protective immunity against HIV-1.
抗病毒β趋化因子的合成,已成为细胞溶解之外的另一种潜在机制,可用于CD8(+) T细胞控制HIV-1感染。最近的证据表明,在一些感染HIV-1的个体中,这两种效应功能可能有所不同;然而,对于正常个体中合成抗病毒β趋化因子的CD8(+) T细胞亚群,我们却知之甚少。在本报告中,我们使用多参数流式细胞术来表征分泌抗病毒β趋化因子巨噬细胞炎性蛋白(MIP)-1β的T细胞亚群。这些研究表明:(i)CD8(+)细胞是合成MIP-1β的主要T细胞亚群;(ii)在大多数CD8(+) T细胞中,MIP-1β和干扰素-γ是协同合成的;然而,有相当数量的这些细胞仅合成这两种效应分子中的一种;(iii)合成MIP-1β的CD8(+) T细胞中,约60%缺乏穿孔素;(iv)CD8(+) T细胞的CD28(+)和CD28(-)亚群合成MIP-1β的频率大致相等;(v)MIP-1β由通过CD45R0和CD62L表达定义的三个不同的CD8(+) T细胞亚群合成;(vi)在初始CD8(+) T细胞的短期培养物中不合成MIP-1β。这些结果表明,CD8(+) T细胞中MIP-1β合成存在显著的亚群异质性,并表明应将这些亚群作为针对HIV-1的保护性免疫的相关指标进行评估。